… Lilly Singapore Centre for Drug Discovery, part of the $20-billion (FY2008 sales) … standards, but would still base its new pharmaceutical research work centrally from Singapore owing to … Singapore. Lilly, whose major products include Adcirca (tadalafil) for pulmonary arterial hypertension, Byetta (exenatide) for …
Eli Lilly eyes India, China for research

Share and Enjoy:
  • Print
  • Digg
  • Sphinn
  • del.icio.us
  • Facebook
  • Mixx
  • Google Bookmarks

Random Posts

Related posts:

  1. Eli Lilly eyes India, China for research – Financial Express
  2. China YCT International Group, Inc. Announces That the State Intellectual Property Office of the People’s Republic of China has Approved a Patent to its Operating Subsidiary, Shandong Spring Pharmaceutical Co. Ltd.
  3. Pfizer Eyes China Growth – Wall Street Journal